# ClinicalTrials.gov record history: NCT03158805

- Peptide profile: [liraglutide](https://peptidescanner.com/peptides/liraglutide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03158805-liraglutide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct03158805.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `d49f759f5e0bbf1df4689c995f6822f3fe8d35193547de76ffc0411373743fec`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2017-05-16 | 2017-05-16 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=1&tab=history) | `59a8f0b8feb6f5bde748d136ef21c14426a682337a1bb1bf804e23c6107765ad` |
| 2 | 2018-08-07 | 2018-08-07 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=2&tab=history) | `acb2f85f8b51f3cc7899758ed85fcc04669520a98efb402e57d97c51ce9576da` |
| 3 | 2019-03-25 | 2019-03-25 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=3&tab=history) | `27cc490297f77c983e9fe84e4202afc5ada6f48afe4a4865d2d746224ce75a17` |
| 4 | 2020-08-31 | 2020-08-31 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=4&tab=history) | `e0f82372d4543d84f45beeca6481247d28bb6fae942c535da7ff0612626c8160` |
| 5 | 2022-05-24 | 2022-05-24 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=5&tab=history) | `d36e6f7f2b038209fc6e6fe031fb9a302d1054026b3d4ec9e1bb25d3a6e66b89` |
| 6 | 2023-03-07 | 2023-03-07 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=6&tab=history) | `d5ee512d3565ccca73d647ac52855f036bb7bdc7a48edb34bcb1815d4ef0a3e6` |
| 7 | 2023-10-05 | 2023-10-05 | COMPLETED | INTERVENTIONAL | Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=7&tab=history) | `0b98e8e1c50d99024c0abe301e0e5674d68ff7089b8f3dd89d5523636e2a853a` |
| 10 | 2024-03-01 | 2024-03-01 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=10&tab=history) | `7e0e8a4feacfe6ec7d3c01870b3c3ae67d3c5665c5d25c25b24fad7654f77ffe` |
| 11 | 2025-03-03 | 2025-03-03 | COMPLETED | INTERVENTIONAL | Limitations and Caveats, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03158805?a=11&tab=history) | `c485ca22c441451ceb2b497cc2c1a4395c104d5662280f1578fe7ea7aff340f7` |